NEWS
Stay tuned for the latest HORUS news
Featured
In this interview, Anaïs discusses her role in validating immune signatures within the HORUS project, highlighting how her work with ELIspot and flow cytometry aims to advance personalised treatment for kidney transplant patients at risk of CMV infection.
Laura Donadeu Casassas plays a key role in standardising immunological techniques within the HORUS project, aiming to improve CMV monitoring and patient outcomes through European collaboration.
This study demonstrates that long-lived central memory γδ T cells (γδ TCM), unlike effector memory γδ T cells (γδ TEM), provide protective immunological memory against chronic cytomegalovirus infection, revealing their adaptive-like features and potential value in vaccine strategies.
We are recruiting a PhD student for the Immunoconcept laboratory to perform his/her PhD, starting in September 2024, on HORUS (Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation) project. HORUS is funded by Horizon Europe and includes 24 partners from 7 European countries.
This significant milestone was achieved through collaborative efforts towards advancing cutting-edge research and innovation. Representatives from all Work Packages came together to provide a comprehensive overview of the project's progress so far.
This article reviews the current state of evidence on using cytomegalovirus (CMV) cell-mediated immunity assays to predict infection risk in solid-organ transplant recipients and concludes that, while promising for enhancing patient management, more validation is needed before they can be routinely implemented.
The General Assembly showcased the dedication and progress of the HORUS project and underscored the spirit of collaboration and innovation that drives this remarkable initiative. The project remains on track to achieve its objectives, furthering the frontiers of scientific research and technological advancement.